Evidence map›Paper›PMID 39995236›Full record

ArticleXenotransplantation

Patients' Information Needs for Informed Consent to Participate in First-in-Human Pig Kidney Xenotransplant Clinical Trials: A Mixed Methods Study.

Elisa J Gordon, Michael K Gusmano, Jessica Gacki-Smith, Hannah L Brooks, Margaret M Matthews, Dahlya Manning, Joseph Leventhal, Karen J Maschke

Abstract read
In one paragraph

Article in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elisa J GordonDepartment of Surgery, Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0003-0969-1998
Michael K GusmanoDepartment of Population Health, College of Health, Lehigh University, Bethlehem, Pennsylvania, USA.ORCID 0000-0002-2337-3067
Jessica Gacki-SmithCenter for Health Services and Outcomes Research, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0002-7000-9014
Hannah L BrooksVanderbilt Institute for Global Health, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-5400-3755
Margaret M MatthewsDepartment of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.ORCID 0009-0006-1477-0972
Dahlya ManningComprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0009-0001-0677-8118
Joseph LeventhalDepartment of Surgery, Division of Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.ORCID 0000-0003-1604-9207
Karen J MaschkeThe Hastings Center, Garrison, New York, USA.ORCID 0009-0009-1069-0053

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Informing Ethical Translation of Xenotransplantation Clinical TrialsR01TR003844 · NCATS · HASTINGS CENTER, INC. · PI GORDON, ELISA J, GUSMANO, MICHAEL KELLEY · 2021 to 2024
$1.9M
NCATS NIH HHS R01 TR003844NCATS NIH HHS R01TR003844NCATS NIH HHS UL1 TR001422
6 · The paper itself

Abstract

backgroundTransplant programs preparing to initiate first-in-human pig kidney xenotransplant clinical trials must be especially careful when obtaining participants' informed consent. Little is known about the kind of information patients want for making an informed decision about trial participation.

methodsWe conducted semi-structured telephone interviews with waitlisted kidney transplant patients about information needs regarding participating in a first-in-human pig kidney xenotransplant trial, which guided development of a prototype consent form. Subsequent usability testing interviews sought patient feedback on the consent form. We analyzed qualitative data by thematic analysis and quantitative data by descriptive statistics.

resultsTwenty-eight patients participated in semi-structured interviews; 16 patients participated in usability testing interviews. Most interview participants were male (68%, 56%), White (54%, 56%), or Black (36%, 31%), respectively. Interview participants identified five types of information needs: (1) the potential for infection contraction and transmission; (2) risks, benefits, and impact of xenotransplant trials; (3) xenotransplant clinical trial and recipient experience; (4) clinical trial logistics; and (5) the pig and its kidney. Usability testing participants suggested adding details to the prototype. Participants' preparedness to make a decision about participating in a xenotransplant trial increased after reviewing the prototype (12.5% vs. 31.3%, n.s.).

conclusionWe identified multiple unique types of information patients desired to make informed decisions about pig kidney xenotransplant trial participation. Transplant programs initiating xenotransplant trials should be prepared to address patients' information needs to optimize informed decision-making for trial participation. The prototype consent form may support a patient-centered approach to informed consent.

Indexed as

HeterograftsInformed ConsentKidney TransplantationTransplantation, HeterologousAdultAgedAnimalsClinical Trials as TopicFemaleHumansMaleMiddle AgedSwineclinical trial participationcomprehensiondisclosureethicsinformation disclosurekidney patientspatient‐centeredpatient‐provider communicationqualitativerecruitmentresearch ethicsxenotransplantation

Identifiers

PMID39995236
PMCPMC11851052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.